Malaria causes a high rate of mortality, especially in children in tropical countries. This situation has been exacerbated with the emergence and spread of multiple drug-resistant malaria and insecticide- resistance in the vector. Thus, there is a need for intensive research in vaccine development, but first, one needs to know what constitutes naturally acquired immunity. This study is designed to determine when an infant first becomes infected, and then compares the immune response of the infant before and after infection. The longitudinal study will involve 100 newborn infants who will be followed form 0-12 months of age and their blood and serum samples analyzed every other month. Peripheral blood will also be drawn from the mothers at parturition. All serum samples will be screened for antibodies recognizing candidate asexual- and sexual-stage vaccine antigens (MSP-1, MSA-2, Pfs25, AMA-1 Pfs27, Pfs230, and Pfs48/45) by immunoprecipitation and ELISA assays. The immune responses will be correlated with HLA type to determine whether HLA effects the specificity and /or rate of development of protective immunity. Parasite DNA from the red blood cells will be isolated and used to determine if parasites are present, as well as to evaluate parasite diversity. Species diversity will be tested using species- specific oligonucleotide primer pairs to amplify sequences present in the small subunit ribosomal RNA (ssRNA genes of P. falciparum, P. malariae and P. ovale. Identification of the different Plasmodium species by this technique (as opposed to microscopy of blood slides) has the advantage of being more sensitive and accurate; therefore, mixed infections will be easily detectable. Genetic diversity of P. falciparum will be evaluated by restriction fragment length polymorphism (RFLP) analysis using 23 RFLP markers which identify all 14 nuclear chromosomes of P. falciparum. Most of these 23 RFLP probes encode P. falciparum proteins which have been implicated in parasite growth, cytoadherence, immune evasion and drug resistance. Correlation of the serological and genetic diversity data will help in understanding the acquisition of natural immunity to malaria in infants.

Project Start
1998-04-01
Project End
2000-03-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Chang, Sandra P; Kayatani, Alexander K K; Terrientes, Zilka I et al. (2010) Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4. Malar J 9:14
Thévenon, Audrey Davidson; Zhou, James A; Megnekou, Rosette et al. (2010) Elevated levels of soluble TNF receptors 1 and 2 correlate with Plasmodium falciparum parasitemia in pregnant women: potential markers for malaria-associated inflammation. J Immunol 185:7115-22
Taylor, Diane Wallace; Zhou, Aniong; Marsillio, Lauren E et al. (2004) Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women. Infect Immun 72:1603-7
Johnson, Armead H; Leke, Rose G F; Mendell, Nancy R et al. (2004) Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1. Infect Immun 72:2762-71
Xi, Guoling; Leke, Rose G F; Thuita, Lucy W et al. (2003) Congenital exposure to Plasmodium falciparum antigens: prevalence and antigenic specificity of in utero-produced antimalarial immunoglobulin M antibodies. Infect Immun 71:1242-6
Zhou, Ainong; Megnekou, Rosette; Leke, Robert et al. (2002) Prevalence of Plasmodium falciparum infection in pregnant Cameroonian women. Am J Trop Med Hyg 67:566-70
Staalsoe, T; Megnekou, R; Fievet, N et al. (2001) Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis 184:618-26
O'Neil-Dunne, I; Achur, R N; Agbor-Enoh, S T et al. (2001) Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect Immun 69:7487-92
Johnson, A; Leke, R; Harun, L et al. (2000) Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2. Infect Immun 68:2231-6
Ellis, J M; Mack, S J; Leke, R F et al. (2000) Diversity is demonstrated in class I HLA-A and HLA-B alleles in Cameroon, Africa: description of HLA-A*03012, *2612, *3006 and HLA-B*1403, *4016, *4703. Tissue Antigens 56:291-302

Showing the most recent 10 out of 11 publications